PRKN and diabetes mellitus: In ECs, Parkin E3 ubiquitin ligase targets nuclear receptor ERRα, reducing levels of endothelial nitric oxide synthase (eNOS), an enzyme that is crucial for vascular fitness and is altered in vascular complications associated with diabetes and atherosclerosis [24].